Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2000, p. 3036-3038, Vol. 38, No. 8
Division of Infectious Diseases and
Microbiology Laboratory, Tel Aviv Sourasky Medical Center, and
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Received 28 February 2000/Returned for modification 26 April
2000/Accepted 2 June 2000
Although Leminorella spp., members of the family
Enterobacteriaceae, were previously isolated from feces and
urine specimens, clinical correlates have not been studied. We
conducted a retrospective study to investigate the clinical
significance and disease spectrum of these organisms, as well as their
antibiotic susceptibility patterns. Identification and susceptibility
testing were performed by an automated system. Eighteen cases were
identified retrospectively during a 28-month period (1/97 to 4/99),
representing an incidence of 11 cases per 100,000 patient admissions.
The medical records of 14 patients were reviewed. The average patient
age was 67 years, and 78% were males. Patients had multiple and
diverse underlying conditions which might have predisposed them to
infection. Leminorella spp. were classified as definite
pathogens in 43% of the cases, probable pathogens in 29%, and
possible pathogens in 21%. In one case of asymptomatic bacteriuria,
the isolate had no clinical significance. All infections but one were
nosocomial. Clinical syndromes included urinary tract infection in six
patients, surgical site infection in three patients, and primary
bacteremia, peritonitis, respiratory tract infection, and soft tissue
infection in one patient each. Isolates were uniformly susceptible to
imipenem. Other beta-lactam agents had poor activity against the
isolates. We conclude that Leminorella spp. are significant
nosocomial pathogens that are capable of causing a variety of clinical
syndromes and are resistant to multiple antibiotic agents.
The genus Leminorella
consists of gram-negative bacilli belonging to the family
Enterobacteriaceae and was first described as enteric group
57 in 1982. The generic name is derived from Leon Le Minor, a French
microbiologist who has made many contributions to enteric bacteriology
as the head of the National Salmonella Center of France. Although
strains of Leminorella spp. share the general properties of
Enterobacteriaceae, they exhibit only 3 to 16% DNA homology
to other bacteria in this family. Based on genetic differences, they
are divided into three taxa: Leminorella grimontii, L. richardii, and Leminorella sp. strain 3 (2).
Strains of Leminorella spp. are easy to culture and
identify. They are facultative anaerobes which grow on sheep blood and MacConkey agar and are negative for D-mannose fermentation
and positive for tyrosine hydrolysis, hydrogen sulfide production, and
L-arabinose fermentation.
The clinical significance of Leminorella spp. is not clear.
There are no reports of infections caused by Leminorella
spp., and their incidence in clinical specimens is unknown. We
initiated this study to investigate the occurrence, clinical
significance, infection spectrum, and antimicrobial susceptibility of
Leminorella spp. in a tertiary care hospital.
The study was conducted in the Tel Aviv Sourasky Medical Center,
a 1,150-bed tertiary care teaching hospital with approximately 70,000 patient admissions per year. The microbiology laboratory processes over
82,500 clinical specimens annually. Identification of gram-negative
organisms (including Leminorella spp.) and susceptibility testing were performed by an automated system (Microscan; Dade Behring
Inc., West Sacramento, Calif.) using a combined gram-negative identification panel and an automated microbroth dilution method (Neg/Urine Combo Panel; Microscan). Criteria for identification acceptance were >85% agreement (in accordance with manufacturer recommendations). Identification of blood isolates was also confirmed by API 20. Criteria for resistance were evaluated in accordance with
National Committee for Clinical Laboratory Standards guidelines. Records of the Microbiology Laboratory for the period spanning 1 January 1997 to 30 April 1999 were searched retrospectively for
recovery of Leminorella spp. from clinical specimens. The medical records of patients identified by this search were reviewed, and data were entered into a prepared questionnaire. To define infections, we used a modification of Centers for Disease Control and
Prevention guidelines (modified to include community-acquired infections and exclude asymptomatic bacteriuria) (1). An
isolate was classified as a definite pathogen if the patient had
symptoms and signs of infection at the site of isolation and no other
pathogen was isolated from that site, as a probable pathogen if the
patient had symptoms and signs of infection at the site of isolation
but the culture yielded polymicrobial growth or if the
Leminorella sp. was a single isolate but the signs and
symptoms of infection were not definitely related to the site of
isolation, as a possible pathogen if signs and symptoms of infection
were evident but not clearly related to the site of isolation, and as a
nonpathogen if there was no evidence of infection at the time of isolation.
During the 28 months surveyed, Leminorella spp. were
identified in clinical specimens from 18 patients, representing an
incidence of 11 cases per 100,000 patient admissions. There was no
clustering of cases by time or place. The medical records of 14 of the
patients were available for review. The mean age was 67 (range, 10 to
88) years, and 78% of the patients were male. In 12 of 14 cases,
Leminorella spp. were isolated after more than 72 h
(average, 11 days) in the hospital. In one case, they were isolated
from a patient undergoing chemotherapy who had intensive contact with
the health care system, and in one case, the isolate appeared to have
been community acquired.
Patients' characteristics and clinical syndromes are summarized in
Table 1. Signs and symptoms of infection
were evident in 13 of the 14 patients studied. Site-specific signs and
symptoms included dysuria in patients with urinary tract infections
(UTI), purulent sputum production, rales on physical examination of
patients with lower respiratory tract infections, and purulent
drainage, localized tenderness, and redness in patients with soft
tissue infections. The systemic signs and symptoms of infection were as
follows: fever in 57% leukocytosis in 43%, and leukopenia in 7% of
the patients at the time that the Leminorella sp. was
present. In 43% of the cases, Leminorella spp. were
isolated from polymicrobial cultures. Three patients had an additional
focus of infection other than the site of isolation of
Leminorella sp. Using clinical criteria,
Leminorella sp. was classified as a definite pathogen in six
(43%) cases, a probable pathogen in four (29%) cases, and a possible
pathogen in three (21%) cases. In one case (7%),
Leminorella spp. had no clinical significance.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Clinical Significance and Antibiotic Resistance
Patterns of Leminorella spp., an Emerging Nosocomial
Pathogen
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Patients' characteristics and clinical syndromes
Urine was the most common site of isolation. In all cases, urine colony counts were >100,000 CFU/ml. In six of the seven patients, pyuria was present (>25 erythrocytes per high-power field). In three of the seven cases, Leminorella sp. was classified as a definite pathogen. Three patients had an indwelling urinary catheter, and two had recurrent UTI. Indeed, the most common clinical syndrome caused by Leminorella spp. was UTI, which occurred in six patients (43%). In five cases, it was the only pathogen isolated from urine and one patient had a polymicrobial UTI in which the copathogen was Acinetobacter baumanii.
In four patients, Leminorella sp. was isolated from wounds. Three of these patients had undergone surgical procedures prior to isolation of the organism. Two had surgical site infections following orthopedic surgery (not in a cluster). The first was a 43-year-old man who developed a wound infection with Leminorella spp. 7 days following repair of a fractured tibia. The second was an 85-year-old female who developed a wound infection 18 days after repair of a fractured hip. In the latter case, both Leminorella spp. and coagulase-negative staphylococci were isolated from the wound. The other two patients with wound infections were a 59-year-old man with post coronary artery bypass graft Staphylococcus epidermidis sternal osteomyelitis who developed a superinfection with Leminorella spp. and a 56-year-old man with pyoderma gangrenosum who had a soft tissue infection of a lower limb ulcer. In this case, Leminorella spp., S. aureus, and a group A beta-hemolytic streptococcus were isolated from the wound and the Leminorella sp. was classified as a possible pathogen.
The only case of bacteremia was that of a 10-year-old boy with acute myeloid leukemia who had postchemotherapy neutropenia and fever. No other pathogen was isolated at that time, and no localizing signs or symptoms were present. Leminorella sp. was isolated from two out of the three sets of blood samples drawn. We defined this case as primary bacteremia, and Leminorella sp. was classified as a definite pathogen.
A case of secondary peritonitis occurred in a 75-year-old male with diabetes mellitus who had been operated on for a mesenteric vascular event and had a leak from the anastomotic site. The patient developed signs and symptoms of peritonitis and underwent a "second-look" laparotomy. Leminorella sp. was the only organism isolated from the peritoneal fluid.
A case of lower respiratory tract infection involved a 79-year-old female with anoxic brain damage after a myocardial infarction. The patient was mechanically ventilated for a prolonged time. She produced copious amount of purulent sputum in association with fever and leukocytosis. Her chest radiograph was clear, and her sputum grew Leminorella spp., Klebsiella pneumoniae, and coagulase-negative staphylococci.
Antimicrobial susceptibility.
The susceptibilities of the 18 isolates to 15 antimicrobial agents are summarized in Table
2. The isolates were uniformly susceptible to imipenem. Beta-lactam agents (with the exception of
imipenem) had poor activity against Leminorella sp.
isolates. One-half of the isolates or fewer were susceptible to the
following agents: ampicillin, piperacillin (and their combination with
a beta-lactamase inhibitor), expanded- and broad-spectrum
cephalosporins (62% were susceptible to ceftazidime), and aztreonam.
Similarly, the two fluoroquinolones which were tested (levofloxacin and
ciprofloxacin) had poor activity. Over half of the isolates were
resistant to gentamicin. In contrast, amikacin showed very good
activity with intermediate susceptibility in only one isolate.
|
| |
DISCUSSION |
|---|
|
|
|---|
Automated systems identify microorganisms based on multiple biochemical tests and computer analysis. Such systems are gaining popularity because of their ease of use and their ability to process a large number of specimens in a relatively short time. Taxa which were not identified to the species level in the past are now more frequently identified. For some of these "new" organisms, the lack of clinical correlates poses a clinical dilemma for the physician. Leminorella spp. are such species.
To date, Leminorella spp. have been recovered from stool and urine only, with no clinical correlates (2). Our study establishes Leminorella spp. as clinically relevant organisms causing primarily UTI, surgical site infection, peritonitis, bacteremia, soft tissue infection, and probably also lower respiratory tract infection.
Leminorella sp. was cultured almost exclusively after the patients were hospitalized for over 72 h, suggesting that it be considered a nosocomial pathogen. The organisms exhibited resistance to multiple antibiotic agents, with uniform susceptibility only to imipenem and amikacin.
Leminorella sp. infections tended to affect patients compromised by underlying conditions or those with invasive devices and procedures. Seventy-one percent of the patients from whose urine Leminorella spp. were isolated had an indwelling urinary catheter or recurrent UTI. Three of four patients from whose wounds Leminorella spp. were isolated had undergone a surgical procedure a few days before the culture was taken. Leminorella spp. were isolated from the sputum of only one patient. This patient has been mechanically ventilated for a long time before the isolation of Leminorella spp.
Retrospective study data should be viewed with caution. Isolates were not available for further investigation and identification to the species level. However, given the unique phenotypic profile of Leminorella spp. (hydrogen sulfide and L-arabinose positive, urea and lipase negative), errors in identification were very unlikely. Moreover, all of the isolates but one shared a typical antibiotic susceptibility pattern. Salmonella sp. is the only organism reported to be misidentified as a Leminorella sp. (3), but the clinical setting of our patients is not compatible with Salmonella sp. infection. Another limitation of a retrospective design is difficulty in distinguishing between infecting and colonizing organisms. To overcome this obstacle, we employed a set of suitable predefined criteria.
We conclude that Leminorella spp. should be considered significant nosocomial pathogens capable of causing a variety of clinical syndromes which could prove refractory to routine antimicrobial therapy.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, Tel Aviv Sourasky Medical Center, Six, Weizman St., Tel Aviv 64239, Israel. Phone: (972) 3 697 3388. Fax: (972) 3 697 4996. E-mail: ycarmeli{at}mailexcite.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140[CrossRef][Medline]. |
| 2. |
Hickman-Brenner, F. W.,
M. P. Vohra,
G. P. Huntley-Carter,
G. R. Fanning,
V. A. Lowery, 3rd,
D. J. Brenner, and J. J. Farmer, 3rd.
1985.
Leminorella, a new genus of Enterobacteriaceae: identification of Leminorella grimontii sp. nov. and Leminorella richardii sp. nov. found in clinical specimens.
J. Clin. Microbiol.
21:234-239 |
| 3. |
Kitch, T. T.,
M. R. Jacobs, and P. C. Appelbaum.
1994.
Evaluation of RapID onE system for identification of 379 strains in the family Enterobacteriaceae and oxidase-negative, gram-negative nonfermenters.
J. Clin. Microbiol.
32:931-934 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»